...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote reminder
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Toinv
Anxious to get info from corporate - especially regarding the timetable to get these products to market and revenue generation. Expecting detailed, specific, concrete corporate plans and timetables. 
Is that too much to expect from Zenith leadership?

Chicagoest

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply